Grand Pharmaceutical Group Limited (Grand Pharma) filed its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited covering the period ended 30 April 2026. The document confirms a stable capital structure with no share movements during the month.

Authorised Capital • Authorised share capital stayed at 100.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 1.00 billion.

Issued Shares • Issued ordinary shares (excluding treasury shares) remained unchanged at 3.55 billion. • The company held no treasury shares.

Public Float • Grand Pharma affirmed compliance with the Main Board’s minimum 25 % public-float requirement as at month-end.

Share-Related Instruments • No share options, warrants, convertibles or other agreements to issue shares were outstanding or exercised during April 2026.

Compliance Confirmation • Company Secretary Victor Foo Tin Chung confirmed on 4 May 2026 that all reporting and regulatory obligations related to issued securities have been duly met.